Jin Sun Kim

Title: Innovations in Cancer Treatment by Jin Sun Kim

Introduction

Jin Sun Kim is a notable inventor based in Seoul, South Korea. She has made significant contributions to the field of cancer treatment through her innovative research and patents. Her work focuses on the suppression of cancer metastasis, which is a critical area in oncology.

Latest Patents

Jin Sun Kim holds a patent for a composition aimed at the treatment or metastasis suppression of cancers. This composition includes a p34 expression inhibitor or activity inhibitor as an active ingredient. The invention details how the knock-down of the p34 protein leads to monoubiquitination of PTEN, inducing its nuclear localization. This process inhibits the Akt pathway, which is associated with tumor survival, proliferation, and metastasis. As a result, the invention significantly reduces the clonogenic potential and tumor-forming ability of various cancer cells that express both PTEN and NEDD4-1. This innovative approach positions the p34 gene expression inhibitor or p34 protein activity inhibitor as a promising treatment or metastasis suppression agent for cancers.

Career Highlights

Throughout her career, Jin Sun Kim has worked with esteemed organizations, including the Asan Foundation and the University of Ulsan Foundation for Industry Cooperation. Her experience in these institutions has allowed her to advance her research and contribute to significant developments in cancer treatment.

Collaborations

Jin Sun Kim has collaborated with various professionals in her field, including her coworker Dong Hoon Jin. Their joint efforts have furthered research initiatives and innovations in cancer therapies.

Conclusion

Jin Sun Kim's contributions to cancer treatment through her innovative patent highlight her role as a leading inventor in the field. Her work not only advances scientific understanding but also offers hope for effective cancer therapies.